Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ketamine Anesthesia Does Not Improve Depression Scores in Electroconvulsive Therapy: A Randomized Clinical Trial
Charles William Carspecken, Anna Borisovskaya, Shu-Tsui Lan, et al.
Journal of Neurosurgical Anesthesiology (2018) Vol. 30, Iss. 4, pp. 305-313
Closed Access | Times Cited: 57

Showing 1-25 of 57 citing articles:

<p>Ketamine and depression: a narrative review</p>
Alexandrine Corriger, Gisèle Pickering
Drug Design Development and Therapy (2019) Vol. Volume 13, pp. 3051-3067
Open Access | Times Cited: 183
Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms
Antonio Inserra, Danilo De Gregorio, Gabriella Gobbi
Pharmacological Reviews (2020) Vol. 73, Iss. 1, pp. 202-277
Open Access | Times Cited: 161
Ketamine for the treatment of mental health and substance use disorders: comprehensive systematic review
Zach Walsh, Özden Merve Mollaahmetoğlu, Joseph M. Rootman, et al.
BJPsych Open (2021) Vol. 8, Iss. 1
Open Access | Times Cited: 120
Ketamine and other glutamate receptor modulators for depression in adults with unipolar major depressive disorder
Rebecca Dean, Cristina Hurducas, Keith Hawton, et al.
Cochrane library (2021) Vol. 2021, Iss. 11
Open Access | Times Cited: 73
Brain-Derived Neurotrophic Factor (BDNF) as a biomarker of treatment response in patients with Treatment Resistant Depression (TRD): A systematic review & meta-analysis
Shakila Meshkat, Yazen Alnefeesi, Muhammad Youshay Jawad, et al.
Psychiatry Research (2022) Vol. 317, pp. 114857-114857
Closed Access | Times Cited: 42
Effects of esketamine on postoperative negative emotions and early cognitive disorders in patients undergoing non-cardiac thoracic surgery: A randomized controlled trial
Tianyuan Luo, Zhimin Deng, Qiyang Ren, et al.
Journal of Clinical Anesthesia (2024) Vol. 95, pp. 111447-111447
Open Access | Times Cited: 14
Rapid-acting antidepressant drugs modulate affective bias in rats
Justyna K. Hinchcliffe, Sarah A. Stuart, Christian M. Wood, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 729
Open Access | Times Cited: 8
Antidepressant-Like Effects and Cognitive Enhancement of Coadministration of Chaihu Shugan San and Fluoxetine: Dependent on the BDNF-ERK-CREB Signaling Pathway in the Hippocampus and Frontal Cortex
Lijing Yan, Xia Xu, Zhenyu He, et al.
BioMed Research International (2020) Vol. 2020, pp. 1-12
Open Access | Times Cited: 66
Ketamine and nitrous oxide: The evolution of NMDA receptor antagonists as antidepressant agents
Molly C. Kalmoe, Alvin M. Janski, Charles F. Zorumski, et al.
Journal of the Neurological Sciences (2020) Vol. 412, pp. 116778-116778
Open Access | Times Cited: 59
Ketamine-induced changes in plasma brain-derived neurotrophic factor (BDNF) levels are associated with the resting-state functional connectivity of the prefrontal cortex
Marie Woelfer, Meng Li, Lejla Čolić, et al.
The World Journal of Biological Psychiatry (2019) Vol. 21, Iss. 9, pp. 696-710
Closed Access | Times Cited: 55
Recent Advances in the Treatment of Treatment-Resistant Depression: A Narrative Review of Literature Published from 2018 to 2023
J Havlík, Syed Shabab Wahid, Kayla M. Teopiz, et al.
Current Psychiatry Reports (2024) Vol. 26, Iss. 4, pp. 176-213
Closed Access | Times Cited: 6
Sub-anesthetic and anesthetic ketamine produce different long-lasting behavioral phenotypes (24 h post-treatment) via inducing different brain-derived neurotrophic factor (BDNF) expression level in the hippocampus
Chunhui Wu, Yu Wang, Yang He, et al.
Neurobiology of Learning and Memory (2019) Vol. 167, pp. 107136-107136
Closed Access | Times Cited: 48
Adjunctive ketamine and electroconvulsive therapy for major depressive disorder: A meta-analysis of randomized controlled trials
Wei Zheng, Xiao-Hong Li, Xiaomin Zhu, et al.
Journal of Affective Disorders (2019) Vol. 250, pp. 123-131
Closed Access | Times Cited: 46
Comparative efficacy and tolerability of different anesthetics in electroconvulsive therapy for major depressive disorder: A systematic review and network meta-analysis
Li Ren, Jian Yu, Jie Zeng, et al.
Journal of Psychiatric Research (2024) Vol. 171, pp. 116-125
Closed Access | Times Cited: 4
Electroconvulsive therapy combined with esketamine improved depression through PI3K/AKT/GLT-1 pathway
Xiangyang Zang, Jingting Zhang, Jingping Hu, et al.
Journal of Affective Disorders (2024) Vol. 368, pp. 282-294
Closed Access | Times Cited: 4
Factors Associated With Delirium Following Electroconvulsive Therapy
Takashi Tsujii, Takahito Uchida, Takefumi Suzuki, et al.
Journal of Ect (2019) Vol. 35, Iss. 4, pp. 279-287
Closed Access | Times Cited: 31
BDNF blood levels after electroconvulsive therapy in patients with mood disorders: An updated systematic review and meta-analysis
Rebeca Pelosof, Leonardo Afonso dos Santos, Luís C. Farhat, et al.
The World Journal of Biological Psychiatry (2022) Vol. 24, Iss. 1, pp. 24-33
Closed Access | Times Cited: 18
Effects of Ketamine Anesthesia on Efficacy, Tolerability, Seizure Response, and Neurocognitive Outcomes in Electroconvulsive Therapy
Nicholas J. Ainsworth, Amir A. Sepehry, Fidel Vila‐Rodriguez
Journal of Ect (2019) Vol. 36, Iss. 2, pp. 94-105
Closed Access | Times Cited: 24
The effect of antidepressant treatment on blood BDNF levels in depressed patients: A review and methodological recommendations for assessment of BDNF in blood
Clara Aabye Madsen, Miriam L. Navarro, Betina Elfving, et al.
European Neuropsychopharmacology (2024) Vol. 87, pp. 35-55
Closed Access | Times Cited: 2
Ketamine-induced regulation of TrkB-GSK3β signaling is accompanied by slow EEG oscillations and sedation but is independent of hydroxynorketamine metabolites
Samuel Kohtala, Wiebke Theilmann, Marko Rosenholm, et al.
Neuropharmacology (2019) Vol. 157, pp. 107684-107684
Open Access | Times Cited: 20
Intermittent administration of low dose ketamine can shorten the course of electroconvulsive therapy for depression and reduce complications: A randomized controlled trial
Jun Dong, Su Min, Haitang Qiu, et al.
Psychiatry Research (2019) Vol. 281, pp. 112573-112573
Closed Access | Times Cited: 19
Effectiveness and Safety of Ketamine for Unipolar Depression: a Systematic Review
Raheel Imtiaz Memon, Sadiq Naveed, Amber E Faquih, et al.
Psychiatric Quarterly (2020) Vol. 91, Iss. 4, pp. 1147-1192
Closed Access | Times Cited: 17
Ketamine and depression
Kazuyoshi Hirota, David G. Lambert
British Journal of Anaesthesia (2018) Vol. 121, Iss. 6, pp. 1198-1202
Open Access | Times Cited: 17
A Chinese Classical Prescription Chaihu Shugan Powder in Treatment of Post-Stroke Depression: An Overview
Zu Gao, Yuan Wang, Huayun Yu
Medicina (2022) Vol. 59, Iss. 1, pp. 55-55
Open Access | Times Cited: 9
Plasma Brain-Derived Neurotrophic Factor Levels in First-Episode and Recurrent Major Depression and before and after Bright Light Therapy in Treatment-Resistant Depression
Biljana Kosanovic Rajacic, Marina Šagud, Dražen Begić, et al.
Biomolecules (2023) Vol. 13, Iss. 9, pp. 1425-1425
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top